These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 36639319)
21. Intracellular distribution of the Wilson's disease gene product (ATPase7B) after in vitro and in vivo exogenous expression in hepatocytes from the LEC rat, an animal model of Wilson's disease. Nagano K; Nakamura K; Urakami KI; Umeyama K; Uchiyama H; Koiwai K; Hattori S; Yamamoto T; Matsuda I; Endo F Hepatology; 1998 Mar; 27(3):799-807. PubMed ID: 9500710 [TBL] [Abstract][Full Text] [Related]
22. [COPPER METABOLISM AND WILSON'S DISEASE]. LANGE J Verh Dtsch Ges Inn Med; 1964; 70():330-7. PubMed ID: 14294237 [No Abstract] [Full Text] [Related]
28. Biomarkers for diagnosis of Wilson's disease. Ryan A; Nevitt SJ; Tuohy O; Cook P Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31743430 [TBL] [Abstract][Full Text] [Related]
29. Copper metabolism after living donor liver transplantation for hepatic failure of Wilson's disease from a gene mutated donor. Kobayashi S; Ochiai T; Hori S; Suzuki T; Shimizu T; Gunji Y; Shimada H; Yamamoto S; Ogawa A; Kohno Y; Sunaga M; Shimazu M; Tanaka K Hepatogastroenterology; 2001; 48(41):1259-61. PubMed ID: 11677941 [TBL] [Abstract][Full Text] [Related]
30. Observations on copper metabolism in Wilson's disease. Czlonkowska A; Galewicz A; Rodo M; Wehr H Acta Univ Carol Med Monogr; 1973; 56():175-7. PubMed ID: 4791768 [No Abstract] [Full Text] [Related]
31. Wilson's disease gene is homologous to hts causing abnormal copper transport in Long-Evans cinnamon rats. Muramatsu Y; Yamada T; Miura M; Sakai T; Suzuki Y; Serikawa T; Tanzi RE; Matsumoto K Gastroenterology; 1994 Oct; 107(4):1189-92. PubMed ID: 7926469 [TBL] [Abstract][Full Text] [Related]
32. Metabolic aspects of Wilson's disease: a review. SIMPSON JF Med Bull (Ann Arbor); 1963; 29():145-54. PubMed ID: 13977562 [No Abstract] [Full Text] [Related]
33. Wilson's disease: presymptomatic patients and Kayser-Fleischer rings. Rodman R; Burnstine M; Esmaeli B; Sugar A; Martonyi C; Johnson V; Brewer G Ophthalmic Genet; 1997 Jun; 18(2):79-85. PubMed ID: 9228244 [TBL] [Abstract][Full Text] [Related]
35. Wilson's disease patients with normal ceruloplasmin levels. Yüce A; Koçak N; Ozen H; Gürakan F Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682 [TBL] [Abstract][Full Text] [Related]
36. [Aspects of chemical pathology in 2 cases of Wilson's disease]. Alloro L; Pecorari T Riv Sper Freniatr Med Leg Alien Ment; 1968 Oct; 92(5):1381-401. PubMed ID: 5738558 [No Abstract] [Full Text] [Related]
38. Copper disposition of the fetus and placenta in a patient with untreated Wilson's disease. Oga M; Matsui N; Anai T; Yoshimatsu J; Inoue I; Miyakawa I Am J Obstet Gynecol; 1993 Jul; 169(1):196-8. PubMed ID: 8333453 [TBL] [Abstract][Full Text] [Related]
39. Hepatolenticular degeneration (Wilson's disease) and pregnancy. A review and report of a case. Toaff R; Toaff ME; Peyser MR; Streifler M Obstet Gynecol Surv; 1977 Aug; 32(8):497-507. PubMed ID: 331163 [TBL] [Abstract][Full Text] [Related]
40. Studies on copper, caeruloplasmin and cirrhosis in relation to Wilson's disease. Williams AO Br J Exp Pathol; 1965 Oct; 46(5):564-8. PubMed ID: 5838405 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]